Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Brain Sciences
    • Study
    • Research
    • About the Faculty
    • Institutes and Divisions
    • Active parent page: News and Events
    • Contact

Unravelling the network of brain tumour genetics

Researchers at the UCL Queen Square Institute of Neurology have revealed a new map of the network of the genetic changes that drive the development of brain tumours.

4 September 2023

Breadcrumb trail

  • Brain Sciences
  • News and Events

Faculty menu

  • Current page: Faculty news
  • Events

The genetic map, developed by researchers at the UCL Queen Square Institute of Neurology, is analogous to a map of the London Underground – where different genetic features responsible for driving brain tumours are like stations connected by tracks.

Mapping the genetic changes should enable more accurate prediction of survival than standard diagnostic approaches.

The wide diversity of genetic changes that enable tumour cells to grow has made brain tumours – a common cause of death and disability worldwide – remarkably difficult to treat. Identifying effective treatments requires an understanding of the variable – and highly individual – relation between tumour genetics, patient outcomes, and disease mechanisms. Crucially, because this diversity is due to the interaction between multiple genetic changes in tumour development, it is ideally captured as a network.

Just as the shortest path from a given station to another is best found by analysing the whole network of stations and tracks, the shortest path from normal to abnormal cells in an individual patient is best found by identifying the whole network of possible genetic changes leading to brain tumour development.

In the largest study of its kind, applying state-of-the-art network analysis to tumour genetic data from 4023 patients with brain tumours, drawn over 14 years across 12 countries, researchers at the UCL Queen Square Institute of Neurology have revealed a new map of the network of individual tumour genetic changes in patients with glioma: amongst the hardest brain tumours to treat.

The research is published in the journal Brain.

Derived from data routinely collected during clinical care, the map is demonstrated to enable more accurate prediction of individual patient survival than the ‘gold-standard’ diagnostic’ labels adopted by the World Health Organization. Since the approach does not require new tests, it offers an efficient path to improved, more personalised care without any increase to healthcare costs.

Lead author, Dr James Ruffle (Clinical Research Fellow (Brain Entry Fellowship), Brain Repair & Rehabilitation, UCL Queen Square Institute of Neurology, says: "The treatment of brain tumours is in desperate need of innovation: outcomes have hardly changed over the past 30 years.
A critical step is gaining an understanding of tumour genetic diversity, which we show here to be accessible, but only to data and mathematical models of great size and complexity. A radical change of approach is needed, and we now have the computational tools to bring it into reality.”

The teams’ work was funded by the Wellcome Trust, the Medical Research Council, and the UCLH Biomedical Research Centre.

Links

  • James K Ruffle and others, Brain tumour genetic network signatures of survival, Brain, 2023;, awad199, https://doi.org/10.1093/brain/awad199
  • Dr James Ruffle's academic profile

Source: NIHR UCLH BRC

Image

  • Credit: peterschreiber.media on iStock

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in